Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Neuropsychological and neuroimaging markers in early versus late-onset Alzheimer's disease.

Kaiser NC, Melrose RJ, Liu C, Sultzer DL, Jimenez E, Su M, Monserratt L, Mendez MF.

Am J Alzheimers Dis Other Demen. 2012 Nov;27(7):520-9. doi: 10.1177/1533317512459798.

2.

Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.

Schönknecht OD, Hunt A, Toro P, Guenther T, Henze M, Haberkorn U, Schröder J.

Clin EEG Neurosci. 2011 Apr;42(2):71-6.

PMID:
21675596
3.

Amyloid deposition in early onset versus late onset Alzheimer's disease.

Cho H, Seo SW, Kim JH, Suh MK, Lee JH, Choe YS, Lee KH, Kim JS, Kim GH, Noh Y, Ye BS, Kim HJ, Yoon CW, Chin J, Na DL.

J Alzheimers Dis. 2013;35(4):813-21. doi: 10.3233/JAD-121927.

PMID:
23507771
4.

Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.

Ossenkoppele R, Zwan MD, Tolboom N, van Assema DM, Adriaanse SF, Kloet RW, Boellaard R, Windhorst AD, Barkhof F, Lammertsma AA, Scheltens P, van der Flier WM, van Berckel BN.

Brain. 2012 Jul;135(Pt 7):2115-25. doi: 10.1093/brain/aws113.

5.

Comparison of neuropsychological and FDG-PET findings between early- versus late-onset mild cognitive impairment: A five-year longitudinal study.

Kim SH, Seo SW, Yoon DS, Chin J, Lee BH, Cheong HK, Han SH, Na DL.

Dement Geriatr Cogn Disord. 2010;29(3):213-23. doi: 10.1159/000278422.

PMID:
20332639
6.

Executive deficits and regional brain metabolism in Alzheimer's disease.

Woo BK, Harwood DG, Melrose RJ, Mandelkern MA, Campa OM, Walston A, Sultzer DL.

Int J Geriatr Psychiatry. 2010 Nov;25(11):1150-8. doi: 10.1002/gps.2452.

PMID:
20069587
7.

Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Rabinovici GD, Furst AJ, Alkalay A, Racine CA, O'Neil JP, Janabi M, Baker SL, Agarwal N, Bonasera SJ, Mormino EC, Weiner MW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ.

Brain. 2010 Feb;133(Pt 2):512-28. doi: 10.1093/brain/awp326.

8.

Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve.

Mosconi L, Herholz K, Prohovnik I, Nacmias B, De Cristofaro MT, Fayyaz M, Bracco L, Sorbi S, Pupi A.

J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):15-23.

9.

Differentiated clinical presentation of early and late-onset Alzheimer's disease: is 65 years of age providing a reliable threshold?

Palasí A, Gutiérrez-Iglesias B, Alegret M, Pujadas F, Olabarrieta M, Liébana D, Quintana M, Álvarez-Sabín J, Boada M.

J Neurol. 2015 May;262(5):1238-46. doi: 10.1007/s00415-015-7698-3.

PMID:
25791224
10.

Cognitive profiles and neuropsychiatric symptoms in Korean early-onset Alzheimer's disease patients: a CREDOS study.

Park HK, Choi SH, Park SA, Kim HJ, Lee Y, Han SH, Kim EJ, Kim BC, Han HJ, Moon SY, Yang DW, Park KW, Park KH, Yoon B, Seo SW, Na DL, Na HR, Lee JH.

J Alzheimers Dis. 2015;44(2):661-73. doi: 10.3233/JAD-141011.

PMID:
25322926
11.

Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum.

Roy K, Pepin LC, Philiossaint M, Lorius N, Becker JA, Locascio JJ, Rentz DM, Sperling RA, Johnson KA, Marshall GA.

J Alzheimers Dis. 2014;42(1):291-300. doi: 10.3233/JAD-131796.

12.

Hemispheric asymmetries of hypometabolism associated with semantic memory impairment in Alzheimer's disease: a study using positron emission tomography with fluorodeoxyglucose-F18.

Zahn R, Juengling F, Bubrowski P, Jost E, Dykierek P, Talazko J, Huell M.

Psychiatry Res. 2004 Dec 15;132(2):159-72.

PMID:
15598550
13.

Relationship between baseline brain metabolism measured using [¹⁸F]FDG PET and memory and executive function in prodromal and early Alzheimer's disease.

Habeck C, Risacher S, Lee GJ, Glymour MM, Mormino E, Mukherjee S, Kim S, Nho K, DeCarli C, Saykin AJ, Crane PK; Alzheimer’s Disease Neuroimaging Initiative..

Brain Imaging Behav. 2012 Dec;6(4):568-83. doi: 10.1007/s11682-012-9208-x.

14.

Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.

Laforce R Jr, Tosun D, Ghosh P, Lehmann M, Madison CM, Weiner MW, Miller BL, Jagust WJ, Rabinovici GD.

Neuroimage Clin. 2014 Mar 19;4:508-16. doi: 10.1016/j.nicl.2014.03.005.

15.

A comparison of family history of psychiatric disorders among patients with early- and late-onset Alzheimer's disease.

Devi G, Williamson J, Massoud F, Anderson K, Stern Y, Devanand DP, Mayeux R.

J Neuropsychiatry Clin Neurosci. 2004 Winter;16(1):57-62.

PMID:
14990760
16.

Generative FDG-PET and MRI model of aging and disease progression in Alzheimer's disease.

Dukart J, Kherif F, Mueller K, Adaszewski S, Schroeter ML, Frackowiak RS, Draganski B; Alzheimer's Disease Neuroimaging Initiative..

PLoS Comput Biol. 2013 Apr;9(4):e1002987. doi: 10.1371/journal.pcbi.1002987.

17.

Early-onset Alzheimer's disease: nonamnestic subtypes and type 2 AD.

Mendez MF.

Arch Med Res. 2012 Nov;43(8):677-85. doi: 10.1016/j.arcmed.2012.11.009. Review.

18.

The topography of grey matter involvement in early and late onset Alzheimer's disease.

Frisoni GB, Pievani M, Testa C, Sabattoli F, Bresciani L, Bonetti M, Beltramello A, Hayashi KM, Toga AW, Thompson PM.

Brain. 2007 Mar;130(Pt 3):720-30.

19.

Prevalence of Traumatic Brain Injury in Early Versus Late-Onset Alzheimer's Disease.

Mendez MF, Paholpak P, Lin A, Zhang JY, Teng E.

J Alzheimers Dis. 2015;47(4):985-93. doi: 10.3233/JAD-143207.

20.

Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.

Förster S, Yousefi BH, Wester HJ, Klupp E, Rominger A, Förstl H, Kurz A, Grimmer T, Drzezga A.

Eur J Nucl Med Mol Imaging. 2012 Dec;39(12):1927-36. doi: 10.1007/s00259-012-2230-9.

PMID:
22926714
Items per page

Supplemental Content

Support Center